Home > Novo Nordisk Inc. (NNI) Products > Diabetes Products
Novo Nordisk Inc. (NNI) Products
Novo Nordisk has multiple products on the market for the treatment of Diabetes, Obesity, Growth Hormone Disorders, Hemophilia and Rare Bleeding Disorders. Access information and resources on each of our products below.
Diabetes
Tresiba®
(insulin degludec injection) 100 U/mL, 200 U/mL
Tresiba® (insulin degludec) injection is a long-acting human insulin analog indicated to improve glycemic control in patients 1 year of age and older with diabetes mellitus.
Levemir®
(insulin detemir injection) 100 U/mL
Levemir® (insulin detemir) injection is a long-acting basal insulin indicated to improve glycemic control in adults and children with diabetes mellitus.
Fiasp®
(insulin aspart injection) 100 U/mL
Fiasp® (insulin aspart) injection is a rapid-acting human insulin analog indicated to improve glycemic control in adult and pediatric patients with diabetes mellitus.
type 1
diabetes
type 2
diabetes
Test Mediums
Scientific Exchange is a trademark of Novo Nordisk Health Care AG.
Novo Nordisk is a registered trademark of Novo Nordisk A/S.
Non-US Health Care Professionals, please go to www.novonordiskpro.com.